Abu Dhabi National Energy Co PJSC Publication of Final Terms

RNS Number : 3291H

Abu Dhabi National Energy Co PJSC

08 October 2024

 

Abu Dhabi National Energy Company PJSC

Publication of Final Terms

 

The following final terms (the Final Terms) are available for viewing:

1.         Final Terms in relation to the issue of U.S.$900,000,000 4.375 per cent. Notes due 2031 by the Abu Dhabi National Energy Company PJSC (the Issuer) under the Issuer's U.S.$20,000,000,000 Global Medium Term Note Programme (the Programme)

2.         Final Terms in relation to the issue of U.S.$850,000,000 4.750 per cent. Green Notes due 2037 by the Issuer under the Programme

To view the full document, please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/3291H_1-2024-10-8.pdf

http://www.rns-pdf.londonstockexchange.com/rns/3291H_2-2024-10-8.pdf

For further information, please contact:

 

Mohammad Sharafi (Chief Legal Officer and Board Secretary); and

Flavio Simonutti (Vice President, Treasury, Insurance and Risk)

 

Abu Dhabi National Energy Company PJSC

Level 25, Al Maqam Tower

ADGM Square, Al Maryah Island

P.O. Box 55224, Abu Dhabi

United Arab Emirates

 

Telephone:      [phone]

Email:             [e-mail]

[e-mail] 

 

 

DISCLAIMER - INTENDED ADDRESSEES

 

The Final Terms referred to above must be read in conjunction with the base prospectus dated 18 July 2024, as supplemented by a supplement dated 1 October 2024 in respect of the Programme (together the Base Prospectus) for the purposes of the Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

Please note that the information contained in the Base Prospectus and the Final Terms may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Final Terms and/or the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms and/or the Base Prospectus is not addressed.  Prior to relying on the information contained in the Final Terms and the Base Prospectus you must ascertain from the Final Terms and the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

 

This publication does not constitute an offering of securities for sale in the United States. The securities discussed herein have not been and will not be registered under the United States Securities Act of 1933, as amended (the Securities Act) or with any securities regulatory authority of any state or other jurisdiction of the United States, and the securities may not be offered or sold in the United States of America or to, or for the account or benefit of, U.S. persons (as defined in the Securities Act), absent registration or an exemption from registration under the Securities Act. No public offering of securities is being or will be made in the United States of America.

 

The Final Terms has been made available to you in an electronic form. You are reminded that documents transmitted via this medium may be altered or changed during the process of electronic transmission and consequently none of the Issuer, its advisers nor any person who controls any of them nor any director, officer, employee nor agent of it or affiliate of any such person accepts any liability or responsibility whatsoever in respect of any difference between the Final Terms made available to you in electronic format and the hard copy version available to you on request from the Issuer.

 

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

PFTGUBDGIDGDGSI